2020 WEF Annual Meeting: Presenting the findings of the 2020 Antimicrobial Resistance Benchmark
Date
23 January 2020
During the 2020 WEF Annual Meeting, the Benchmark will be presented on Thursday 23 January in an Affiliated Session titled “Securing the Future of Healthcare Through Access to New and Essential Antibiotics: The 2020 Antimicrobial Resistance Benchmark.”
The high-level roundtable will feature the results of the 2nd AMR Benchmark report, showing how leading pharmaceutical companies are tackling drug-resistant infections. Participants will then discuss how governments, investors, companies and civil society organisations can work together to revitalise the current infrastructure that develops and deploys new and essential antibiotics for patients. The session will also include the announcement of the ‘Investor Year of Action on AMR'.
The session will be opened by Mr Bruno Bruins, Dutch Minister for Medical Care, and moderated by Professor Dame Sally Davies, UK Special Envoy on AMR and co-convener of the UN Interagency Coordination Group on AMR. Speakers include:
Thomas Breuer, Chief Medical Officer, GSK Vaccines
Jeremy Coller, CIO and Chairman, Coller Capital
Elizabeth Cousens, President and CEO, UN Foundation
Alex Harris, Head of Global Policy and Advocacy, Wellcome Trust
Charlotte Petri Gornitzka, UN Assistant Secretary-General and Deputy Executive Director, Partnerships, UNICEF
Peter Sands, Executive Director, Global Fund to Fight AIDS, Tuberculosis and Malaria
Registered participants of the WEF Annual Meeting can use TopLink to join the meeting. If you don't have a badge for the Annual Meeting, but plan to be in Davos, please get in touch with Damiano de Felice to access to the session.